Cord Blood Registry Announces Settlement of Litigation with Viacord.
SAN BRUNO, Calif., Oct. 27 /PRNewswire/ -- Cord Blood cord blood
Blood present in the umbilical vessels at the time of delivery. Registry ("Cbr") announced today that it has entered into a settlement agreement with Viacord, a division of Viacell, Inc. regarding litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute.
When a person begins a civil lawsuit, the person enters into a process called litigation. involving marketing and advertising claims. Under the terms of the settlement agreement, no financial payment will be made by either company, and both companies will dismiss all outstanding claims. No additional terms of the settlement were disclosed.
"We are pleased with the outcome of this settlement," said Tom Moore, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Cbr.
Cbr is the world's largest newborn stem cell stem cell
In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult. bank. Cbr's laboratory has been collecting and processing newborn stem cells for family banking since 1992. The company has recorded profits and positive cash flow from its operating activities since 1999, with 106% growth in units banked for the first nine months of 2005 as compared with the first nine months of 2004. Over 350,000 units of cord blood for more than 105,000 newborns are preserved at Cbr's new 80,000-square-foot stem cell facility in Tucson, Arizona. The company's research and development is focused on advancing the collection, processing, and storage methods to deliver the highest quality sample and cell yield. Additionally, Cbr provides donated research samples which are made available for the nearly 200 research programs worldwide that are focused on cord blood stem cell expansion and cell-based therapies. For more information, visit http://www.cordblood.com/, or call 1-888-CORD BLOOD.
Cord Blood Registry is a registered trademark of Cbr Systems, Inc. Contact: Rita Kennen Media Relations Manager 650-635-1420 ext. 239 firstname.lastname@example.org
CONTACT: Rita Kennen, Media Relations Manager of Cord Blood Registry, +1-650-635-1420, ext. 239, or email@example.com
Web site: http://www.cordblood.com/